Akanda Corp.
Sector: Communications Services, NECIndustry: Drug Manufacturers - Specialty & GenericCountry: CAExchange: Nasdaq
DilutionScan read 37 of AKANDA CORP.'s SEC filings and found 4 convertibles, 1 shelf registration, 5 S-1 registrations and 2 completed offerings on file for AKAN. The latest dilution event on file is a registration statement on Oct 1, 2026. Analysis updated Oct 29, 2026.
Signal8 Summary
AKAN
Going-concern warning and delisting risk
Snapshot
Akanda is a distressed micro-cap with a $1.7 million market cap that is burning cash faster than it earns revenue. The company lost $4.1 million in FY 2024 on just $837,000 in revenue, a classic distress signal where losses are nearly five times the top line. Revenue has collapsed 61% year-over-year, and the business generated negative $6.1 million in free cash flow.
What's Happening Right Now
- : The company regained compliance with Nasdaq filing rules after submitting its late annual report, resolving an immediate threat of delisting that had been raised in May.
- : Akanda filed its annual report disclosing substantial doubt about its ability to continue as a going concern, citing reliance on uncertain future funding and $20 million in debt from a recent acquisition.
- : Akanda implemented a 1-for-4.5 reverse stock split in April, the third such split in the last 12 months, a pattern typically associated with stocks under severe pressure.
- : Akanda expanded its Mexican fiber optic subsidiary's network by 200 kilometers, aiming to build a cash-generating digital infrastructure platform in Latin America.
